文献速递白内障与屈光手术

即刻连续与延迟连续双侧白内障手术:术后视觉结局的回顾性比较

Immediate Sequential vs. Delayed Sequential Bilateral Cataract Surgery: Retrospective Comparison of Postoperative Visual Outcomes.
PubMed 文献 · Ophthalmology · 2017-04-21

这项回顾性比较效果研究纳入2013年1月1日至2015年6月30日在Kaiser Permanente北加州接受非复杂双侧白内障手术的患者,比较即刻连续双侧白内障手术(ISBCS)与延迟连续双侧白内障手术(DSBCS)的术后最佳矫正视力(BCVA)和屈光误差(RE)。结果显示ISBCS与DSBCS相比,术后BCVA或RE无更差证据,也未增加并发症风险。

要点

  • ISBCS与DSBCS术后BCVA和屈光误差无临床显著差异。
  • 术后BCVA达20/20或更好:DSBCS第一眼48%、第二眼49%,ISBCS右眼53%、左眼51%。
  • 眼内炎发生率ISBCS为1.0/万眼,DSBCS为0.5/万眼(P=0.6),无双眼眼内炎。

核心结论

  • 与DSBCS相比,未发现ISBCS与术后BCVA或RE更差或并发症风险增加相关的证据。

研究设计与样本

  • 回顾性比较效果研究,采用意向性治疗分析,使用条件逻辑回归分析并校正手术医生和患者层面因素。
  • 研究对象为2013年1月1日至2015年6月30日在Kaiser Permanente北加州接受非复杂双侧白内障手术的会员。
  • 分析纳入13711例DSBCS和3561例ISBCS患者的双眼视觉结局。

主要发现

  • 术后BCVA达20/20或更好:DSBCS第一眼48%、第二眼49%,ISBCS右眼53%、左眼51%。
  • DSBCS第一眼与第二眼之间、ISBCS右眼与左眼之间,术后BCVA的个体内差异平均为零(0.00)。
  • 校正后ISBCS患者平均术后BCVA更好,但差异无统计学显著(以20/20或更好为参照,差于20/20的比值比为0.91,95%CI 0.83-1.01)。
  • 达到正视(等效球镜-0.5至0屈光度):DSBCS第一眼61%、第二眼61%,ISBCS右眼63%、左眼63%。
  • 校正后ISBCS与DSBCS患者平均术后RE无差异(以正视为参照,非正视的比值比为1.02,95%CI 0.92-1.12)。

关键数值与推荐

  • 术后BCVA达20/20或更好:DSBCS第一眼48%、第二眼49%,ISBCS右眼53%、左眼51%。
  • 达到正视(等效球镜-0.5至0屈光度):DSBCS第一眼61%、第二眼61%,ISBCS右眼63%、左眼63%。
  • 校正后差于20/20的比值比0.91(95%CI 0.83-1.01),非正视的比值比1.02(95%CI 0.92-1.12)。
  • 眼内炎发生率ISBCS 1.0/万眼 vs DSBCS 0.5/万眼(P=0.6)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出因样本量大,部分统计学差异缺乏临床意义。
  • 原文指出DSBCS患者眼部合并症略更常见。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We conducted a retrospective comparative-effectiveness study of best-corrected visual acuity (BCVA) and refractive error (RE) after immediate sequential (ISBCS) and delayed sequential (DSBCS) bilateral cataract surgery. We tested 2 hypotheses: (1) among DSBCS patients, second-eye outcomes were no different than first-eye outcomes; (2) averaged between each patient's 2 eyes, outcomes did not differ between ISBCS and DSBCS patients. DESIGN: Retrospective comparative-effectiveness study. PARTICIPANTS: Kaiser Permanente Northern California members who underwent noncomplex bilateral cataract surgery from January 1, 2013, through June 30, 2015. METHODS: We performed an intention-to-treat analysis comparing ISBCS to DSBCS using conditional logistic regression analysis, accounting for surgeon and patient-level factors. MAIN OUTCOME MEASURES: BCVA, RE. RESULTS: The analysis of visual outcomes included both eyes of 13 711 DSBCS and 3561 ISBCS patients. Because of the large sample size, some statistical differences lacked clinical significance. Ocular comorbidities were slightly more prevalent in DSBCS patients. Postoperative BCVA was 20/20 or better in 48% of DSBCS first eyes, 49% of DSBCS second eyes, 53% of ISBCS right eyes, and 51% of ISBCS left eyes. The within-person difference in postoperative BCVA averaged zero (0.00) between the first and second DSBCS eyes, and between the ISBCS right and left eyes. After adjustment, average postoperative BCVA was better in ISBCS patients, although the difference was not statistically significant (compared with 20/20 or better: odds ratio for worse than 20/20 was 0.91, 95% confidence interval 0.83-1.01). Emmetropia (spherical equivalent -0.5 to 0 diopter) was achieved in 61% of first DSBCS eyes, 61% of second DSBCS eyes, 63% of ISBCS right eyes, and 63% of ISBCS left eyes. After adjustment, average postoperative RE was no different in ISBCS compared with DSBCS patients (compared with emmetropia: odds ratio for ametropia was 1.02, confidence interval 0.92-1.12). We confirmed 1 case of postoperative endophthalmitis in 10 494 ISBCS eyes (1.0 per 10 000 eyes) and 2 cases in 38 736 DSBCS eyes (0.5 per 10 000 eyes) (P = 0.6), and no patient had bilateral endophthalmitis. CONCLUSIONS: Compared with DSBCS, we found no evidence that ISBCS was associated with worse postoperative BCVA or RE, or with an increased complication risk.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Herrinton LJ, Liu L, Alexeeff S, et al. Immediate Sequential vs. Delayed Sequential Bilateral Cataract Surgery: Retrospective Comparison of Postoperative Visual Outcomes. Ophthalmology. 2017. PMID: 28438415. doi:10.1016/j.ophtha.2017.03.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。